University Hospital Tübingen at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
University Hospital Tübingen brings 7 presentations to SITC 2026 in Phoenix. Its program centres on bispecific and trispecific antibodies built to switch on T cells only at the tumor, and on personalized peptide vaccines. One concrete item is an early trial of a vaccine aimed at a fusion gene found in fibrolamellar carcinoma and other tumors.
| Organization | SITC 2026 Attendance |
|---|---|
University Hospital Tübingen Tübingen, Germany | |
Plenary Fri Nov 6 10:57am–11:10am Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from University Hospital Tübingen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction